Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery最新文献

{"title":"Patient-Reported Swallowing Outcomes in HPV+ Oropharyngeal Cancer by Postoperative Chemoradiation Dose in MINT and E3311.","authors":"Theresa Tharakan, Sidharth V Puram, Randal C Paniello, Patrik Pipkorn, Paul Zolkind, Richard Alexander Harbison, Douglas Adkins, Peter Oppelt, Wade Thorstad, Hiram Gay, Anthony J Apicelli, Michael J Moravan, Rebecca Chernock, Mena Mansour, Jessica Ley, Ryan S Jackson","doi":"10.1002/ohn.1261","DOIUrl":"10.1002/ohn.1261","url":null,"abstract":"<p><strong>Objective: </strong>Evaluate the effect of deintensified postoperative adjuvant (chemo)radiation therapy (POA(C)RT) on patient-reported dysphagia outcomes in patients with human papillomavirus (HPV+) oropharyngeal squamous cell carcinoma (OPSCC).</p><p><strong>Study design: </strong>Retrospective.</p><p><strong>Setting: </strong>Multiple institutions, 2014 to 2021.</p><p><strong>Methods: </strong>Patients with HPV+ OPSCC underwent transoral robotic surgery and reduced-dose POA(C)RT by pathologic risk stratification. The Minimalist Trial (MINT) participants received 42 Gy radiation therapy (RT) with one dose of cisplatin 100 mg/m² (intermediate-risk arm) or no cisplatin (low-risk arm). The intermediate-risk E3311 participants were randomized to 50 or 60 Gy RT. Analysis was per-protocol by RT dose group. The primary outcome was change in MD Anderson Dysphagia Inventory (MDADI) composite score from baseline to 1-year posttreatment, with a clinically meaningful decline (CMD) of ≥10 points.</p><p><strong>Results: </strong>In total, 156 included patients received POA(C)RT: n = 28 at 42 to 49 Gy (n = 19 no cisplatin, n = 9 cisplatin), n = 82 at 50 to 59, and n = 46 at 60 Gy. Mean (SD) change in MDADI was -7.2 (10.6) in the 42 to 49 Gy group, -11.3 (17.2) in the 50 to 59 group, and -9.1 (15.1) in the 60 Gy group (analysis of variance [ANOVA] P = .46). The rate of CMD was 11/28 (39%) in the 42 to 49 Gy group, 43/82 (52%) in the 50 to 59 group, and 20/46 (44%) in the 60 Gy group (chi-square P = .42). The rate of CMD was similar in those receiving 42 to 49 Gy with (3/9, 33%) and without cisplatin (8/19, 42%) (diff. 1%, 95% CI -29% to 47%). Gastrostomy tube rates were similar across dose groups.</p><p><strong>Conclusion: </strong>Changes in dysphagia-related quality-of-life (MDADI) from baseline to 1 year after POA(C)RT did not differ by radiation dose in the range of 42 to 60 Gy.</p>","PeriodicalId":520739,"journal":{"name":"Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery","volume":" ","pages":"410-419"},"PeriodicalIF":2.5,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144164688","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Executive Summary of the Clinical Practice Guideline on Adult Sinusitis Update.","authors":"Spencer C Payne, Margo McKenna, Jennifer Buckley, Maria Colandrea, Anthony Chow, Kara Detwiller, Angela Donaldson, Marc Dubin, Sandra Finestone, Anju T Peters, Ayesha Khalid, Richard Rosenfeld, Zarah Akrami, Nui Dhepyasuwan","doi":"10.1002/ohn.1342","DOIUrl":"https://doi.org/10.1002/ohn.1342","url":null,"abstract":"&lt;p&gt;&lt;p&gt;The American Academy of Otolaryngology-Head and Neck Surgery Foundation has published the updated \"Clinical Practice Guideline: Adult Sinusitis\" as a supplement to this issue of Otolaryngology-Head and Neck Surgery. To assist in implementing the guideline recommendations, this article summarizes the rationale, purpose, and key action statements. The 14 developed recommendations address diagnostic accuracy for adult rhinosinusitis, the appropriate use of ancillary tests to confirm diagnosis and guide management (including radiography, nasal endoscopy, computed tomography, and testing for allergy and immune function), and the judicious use of systemic and topical therapy. Emphasis was also placed on identifying multiple chronic conditions that would modify management of rhinosinusitis, including asthma, cystic fibrosis, immunocompromised state, and ciliary dyskinesia. An updated guideline is needed as a result of new clinical trials, new systematic reviews, and the lack of consumer participation in the initial guideline development group. METHODS: This executive summary describes the guideline developed using the 55-page protocol published as the American Academy of Otolaryngology-Head and Neck Surgery Foundation's Clinical Practice Guideline Development Manual (3&lt;sup&gt;rd&lt;/sup&gt; edition), which summarizes the methodology for assessments of current data, topic prioritization, development of key action statements, application of value judgements, and related procedures. The guideline update group represented the disciplines of otolaryngology-head and neck surgery, infectious disease, family medicine, allergy and immunology, advanced practice nursing, and a consumer advocate. DIFFERENCES FROM PRIOR GUIDELINE: This clinical practice guideline is as an update, and replacement, for an earlier guideline published in 2015 by the American Academy of Otolaryngology-Head and Neck Surgery Foundation (AAO-HNSF).&lt;sup&gt;1&lt;/sup&gt; An update was planned for 5 years after the initial publication date and was further necessitated by new primary studies and systematic reviews that might suggest a need for modifying clinically important recommendations.&lt;sup&gt;2&lt;/sup&gt; Changes in content and methodology from the prior guideline include the following: New evidence from 14 guidelines, 194 systematic reviews, and 133 RCTs. Emphasis on patient education and counseling with new explanatory tables. Expanded action statement profiles to explicitly state quality improvement opportunities, confidence in the evidence, intentional vagueness, and differences of opinion. Enhanced external review process to include public comment and journal peer review. New algorithm to clarify decision making, watchful waiting, action statement relationships. Extension of watchful waiting (without antibiotic therapy) as an initial management strategy to all patients with uncomplicated acute bacterial rhinosinusitis (ABRS) regardless of severity, not just patients with \"mild\" illness (prior guideline).","PeriodicalId":520739,"journal":{"name":"Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery","volume":"173 2","pages":"299-316"},"PeriodicalIF":2.5,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144755658","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Clinical Practice Guideline: Adult Sinusitis Update.","authors":"Spencer C Payne, Margo McKenna, Jennifer Buckley, Maria Colandrea, Anthony Chow, Kara Detwiller, Angela Donaldson, Marc Dubin, Sandra Finestone, Peter Filip, Ayesha Khalid, Anju T Peters, Richard Rosenfeld, Zarah Akrami, Nui Dhepyasuwan","doi":"10.1002/ohn.1344","DOIUrl":"https://doi.org/10.1002/ohn.1344","url":null,"abstract":"<p><p>The American Academy of Otolaryngology-Head and Neck Surgery Foundation has published a supplement to this issue of Otolaryngology-Head and Neck Surgery featuring the updated \"Clinical Practice Guideline: Adult Sinusitis\". To assist in implementing the guideline recommendations, this article summarizes the rationale, purpose, and key action statements. The 14 developed recommendations address diagnostic accuracy for adult rhinosinusitis, the appropriate use of ancillary tests to confirm diagnosis and guide management (including radiography, nasal endoscopy, computed tomography, and testing for allergy and immune function), and the judicious use of systemic and topical therapy. Emphasis was also placed on identifying multiple chronic conditions that would modify management of rhinosinusitis, including asthma, cystic fibrosis, an immunocompromised state, and ciliary dyskinesia. An updated guideline is needed as a result of new clinical trials, new systematic reviews, and the lack of consumer participation in the initial guideline development group.</p>","PeriodicalId":520739,"journal":{"name":"Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery","volume":"173 Suppl 1 ","pages":"S1-S56"},"PeriodicalIF":2.5,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144755660","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Questioning the Outcomes of Balloon Dilation of the Eustachian Tube in Children.","authors":"Richard M Rosenfeld","doi":"10.1002/ohn.1271","DOIUrl":"10.1002/ohn.1271","url":null,"abstract":"","PeriodicalId":520739,"journal":{"name":"Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery","volume":" ","pages":"536"},"PeriodicalIF":2.5,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144176481","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Response to Letter to the Editor Regarding \"Outcomes and Complications of Pediatric Eustachian Tube Dilation Surgery\".","authors":"Shraddha Mukerji, Ana Maria Rosas Herrera, Ryan Rochat, Katherine Hosek, Yi-Chun Carol Liu","doi":"10.1002/ohn.1270","DOIUrl":"10.1002/ohn.1270","url":null,"abstract":"","PeriodicalId":520739,"journal":{"name":"Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery","volume":" ","pages":"537"},"PeriodicalIF":2.5,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144176464","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Plain Language Summary: Adult Sinusitis Update.","authors":"Spencer C Payne, Margo McKenna, Maria Colandrea, Kara Detwiller, Sandy Finestone, Anju T Peters, Nui Dhepyasuwan, Zarah Akrami","doi":"10.1002/ohn.1343","DOIUrl":"https://doi.org/10.1002/ohn.1343","url":null,"abstract":"<p><strong>Objective: </strong>This plain language summary is an overview of sinusitis (pronounced sign-you-side-iss). The purpose of this plain language summary is to provide patients with standard language explaining their condition in an easy-to-read format. This summary applies to those 18 years of age or older with sinusitis. The summary is written in an FAQ (frequently asked questions) format. The summary addresses how to manage and treat sinusitis symptoms. A healthcare provider may refer to a sinus infection as sinusitis or rhinosinusitis (pronounced rhi-no-sign-you-site-iss). This includes the nose as well as the sinuses in the name. The summary is based on the published 2025 \"Clinical Practice Guideline: Adult Sinusitis Update.\" The evidence-based guideline includes research to support more effective diagnosis and treatment of adult sinusitis. The guideline was developed as a quality improvement opportunity for managing sinus infections by creating clear recommendations to use in medical practice.</p>","PeriodicalId":520739,"journal":{"name":"Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery","volume":"173 2","pages":"317-323"},"PeriodicalIF":2.5,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144755659","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Radiographic Midfacial Volume Changes in Patients on GLP-1 Agonists.","authors":"Rahul K Sharma, Kelly L Vittetoe, Alexander J Barna, Sahar Takkouche, Antonios N Varelas, Shiayin F Yang, Scott J Stephan, Priyesh N Patel","doi":"10.1002/ohn.1209","DOIUrl":"10.1002/ohn.1209","url":null,"abstract":"<p><strong>Objective: </strong>Facial plastic surgeons report seeing an increase in patients presenting with facial deflation and a prematurely aged appearance-a reported side effect of the weight-loss drug semaglutide. No objective data exist to quantitatively characterize midface volume loss in these patients.</p><p><strong>Study design: </strong>Retrospective cohort study.</p><p><strong>Setting: </strong>Single, tertiary academic medical center.</p><p><strong>Methods: </strong>Hospital-level electronic medical record data were systematically queried for patients with glucagon-like peptide-1 (GLP-1) agonist prescriptions as well as head and neck imaging (computed tomography [CT]/magnetic resonance [MR]) both before and after prescriptions between 2017 and 2024. Changes in total, superficial, and deep midface volume were measured. Spearman correlation and linear regression were conducted to understand the relationship between weight-loss magnitude and facial volume changes.</p><p><strong>Results: </strong>Twenty patients with available imaging were included in the analysis. The median age of patients was 54 years (interquartile range [IQR] 48-61). The average duration of GLP-1 agonists was 321 days (SD = 291), and the average weight loss was 11.0 kg (SD = 6.9). The median percent decrease in total midfacial volume was 9.0% (IQR 3%-14%). Superficial volume decreased by 11.0% (IQR 5%-15%), and deep volume decreased by 7.0% (IQR -20% to 15%). Spearman correlation showed a relationship between weight loss and superficial volume loss (rho = 0.590, P = .006) but not deep volume loss (r = 0.115, P = .629). Linear regression showed a loss of 7% facial volume for every 10 kg of weight lost (r = 0.063, SE = 0.003, P = .0293).</p><p><strong>Conclusion: </strong>Patients on average can expect a loss of 7% of midfacial volume/10 kg of total weight loss, primarily in superficial fat pads. This represents one of the first quantitative assessment of the \"Ozempic face\" phenomenon.</p>","PeriodicalId":520739,"journal":{"name":"Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery","volume":" ","pages":"360-366"},"PeriodicalIF":2.5,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144130066","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Initial Direct Laryngoscopy Versus TORS Alone for Unknown Primary HPV+ Oropharyngeal Squamous Cell Carcinoma.","authors":"Alexander J Jones, Peyton Z Robinson, Deborah X Xie, Janice L Farlow, Michael G Moore, David A Campbell, Jessica A Yesensky, Avinash V Mantravadi, Michael W Sim","doi":"10.1002/ohn.1256","DOIUrl":"10.1002/ohn.1256","url":null,"abstract":"<p><strong>Objective: </strong>This study aims to determine whether initial direct laryngoscopy with biopsy (DLBx) before transoral robotic surgery (TORS) has differences in perioperative outcomes, tumor identification, and oncologic outcomes for unknown primary oropharyngeal human papillomavirus (HPV+) squamous cell carcinoma (OPSCC).</p><p><strong>Study design: </strong>A retrospective cohort.</p><p><strong>Setting: </strong>A single-institution, tertiary referral center.</p><p><strong>Methods: </strong>All patients with HPV+ squamous cell carcinoma and unknown primary (cTx) undergoing TORS from 2014 to 2024 were collected. Patients receiving DLBx + TORS versus TORS alone were compared.</p><p><strong>Results: </strong>A total of 57 patients had no evidence of primary disease on exam, flexible laryngoscopy, and PET/CT imaging, of which 20 (35%) underwent TORS + neck dissection without previous DLBx. Primary tumor was identified on 38% of DLBx and 74% of combined primary and secondary TORS. Only 19% of all cTx patients remained true unknown primary on final pathology (pT0). Demographics and perioperative courses were similar between the two groups. TORS was able to detect primary tumor in the majority of tongue base disease (83%). There were no differences in overall primary tumor size (median 0.8 vs. 1.0 cm), nodal burden, tumor, node, metastasis classification, adjuvant treatment, or 5-year disease-free survival.</p><p><strong>Conclusion: </strong>Initial DLBx for unknown primary HPV+ OPSCC has similar perioperative and oncologic outcomes to performing initial TORS alone and may unnecessarily delay definitive surgery and add healthcare costs.</p><p><strong>Level of evidence: </strong>IV.</p>","PeriodicalId":520739,"journal":{"name":"Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery","volume":" ","pages":"402-409"},"PeriodicalIF":2.5,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12312296/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144228415","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Credibility of Minimal Clinically Important Differences for Otolaryngology Patient-Reported Outcome Measurements: A Scoping Review.","authors":"Maryann Zhao, Lucy Xu, Deborah Goss, Matthew R Naunheim","doi":"10.1002/ohn.1257","DOIUrl":"10.1002/ohn.1257","url":null,"abstract":"<p><strong>Objective: </strong>Anchor-based approaches for determining a minimal clinically important difference (MCID) for patient-reported outcome measures (PROMs) are critical for detecting meaningful changes in clinical status. However, the methodologies for MCID determination vary across the literature and have been found to be inconsistent. Our objective is to evaluate the credibility of anchor-based MCIDs in otolaryngology.</p><p><strong>Data sources: </strong>PubMed, Embase, and Web of Science.</p><p><strong>Review methods: </strong>Studies identifying novel anchor-based MCIDs for PROMs in otolaryngology from inception to November 2, 2021, in a previous review were included. A systematic search of PubMed, Embase, and Web of Science was conducted for original articles on the same topic from November 3, 2021, to January 4, 2024. The credibility of MCIDs was assessed using a previously developed instrument with five main criteria, including anchor interpretability and relevance to patients, correlation between the anchor and the patient-reported outcome, sample size, and determination if the selected anchor threshold is small and meaningful.</p><p><strong>Results: </strong>In total, 43 studies reported anchor-based MCIDs in otolaryngology. A total of 74 MCIDs were identified across subspecialties, most commonly in rhinology (38%) and otology (26%). Only 25% (18/74) were deemed credible, whereas 48% (35/74) had low credibility. In 34% (24/74) of cases, correlations between the anchor and PROMs were not reported. Most MCIDs (70%) were calculated using differences in their anchors that were considered sufficiently small and clinically relevant to patients. All MCIDs were calculated using at least an anchor-based method, with 50 (58%) relying on the mean change anchor-based method.</p><p><strong>Conclusion: </strong>A small subset of MCIDs for PROMs in otolaryngology were found to be credible. These findings highlight the need for more rigorous methods and standardized guidelines for defining MCIDs, ensuring that criteria, such as sufficient sample size and appropriate anchor thresholds, are met.</p>","PeriodicalId":520739,"journal":{"name":"Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery","volume":" ","pages":"332-344"},"PeriodicalIF":2.5,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144164687","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Establishing Usage Patterns and Repair Costs for Video Rhinolaryngoscopes at a Tertiary Academic Outpatient Center.","authors":"Zaid AlMubarak, Kevin Fung, Leigh J Sowerby","doi":"10.1002/ohn.1362","DOIUrl":"https://doi.org/10.1002/ohn.1362","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the financial impact of video rhinolaryngoscope repairs by determining repair costs and assessing the link between reprocessing patterns and repair frequency.</p><p><strong>Study design: </strong>Retrospective review.</p><p><strong>Setting: </strong>Outpatient settings at two tertiary care academic centers.</p><p><strong>Methods: </strong>Repair and maintenance records for video rhinolaryngoscopes were analyzed for two tertiary care academic centers, Hospital V and Hospital S. Data were collected from January 1, 2021, to March 1, 2024, for Hospital S, and from June 18, 2019, to March 1, 2024, for Hospital V. Hospital S utilized automated endoscope reprocessing, whereas Hospital V employed manual reprocessing. Both hospitals used Olympus flexible video rhinolaryngoscopes.</p><p><strong>Results: </strong>Hospital V reprocessed the endoscopes within the clinic space, whereas Hospital S used centralized reprocessing. The age of rhinolaryngoscopes varied at Hospital S, whereas all endoscopes were purchased new at Hospital V during the time of study. Hospital V, with 11 rhinolaryngoscopes, conducted 15,776 outpatient rhinolaryngoscopy examinations, averaging 435 uses per endoscope annually. Only one endoscope required repair, with a total cost of CAD $1940, resulting in a repair cost of CAD $0.12 per examination. In contrast, Hospital S, operating with 17 rhinolaryngoscopes, performed 7812 exams, averaging 145 uses per endoscope annually. A total of 28 repair instances were reported, with a total cost of CAD $87,950, resulting in a repair cost of CAD $11.26 per examination.</p><p><strong>Conclusion: </strong>This study highlights the impact of equipment age and reprocessing practices on repair costs and frequencies for reusable video rhinolaryngoscopes. The repair costs at both hospitals are supportive of continued use of reusable rhinolaryngoscopes.</p>","PeriodicalId":520739,"journal":{"name":"Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2025-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144755653","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}